Company Filing History:
Years Active: 2016-2020
Title: Innovations by Dingqiu Huang: Pioneering Antibody Technologies
Introduction
Dingqiu Huang is an innovative inventor based in San Diego, California, who has made significant contributions to the field of biotechnology through his extensive research and development efforts. Holding a total of 7 patents, Huang's inventive work primarily focuses on the development of groundbreaking antibody formulations that can be used in treating various medical conditions.
Latest Patents
Among Huang's notable inventions are his latest patents involving antigen binding proteins that specifically bind to CCR2 and CXCR3. His patent on CCR2 antibodies encompasses compositions and methods related to fully human antibodies that bind to CCR2, along with various fragments and derivatives of such antibodies. This work includes nucleic acids encoding these antibodies and the methods of utilizing them for diagnosing and treating individuals with CCR2-related disorders.
In a similar vein, his research into CXCR3 antibodies reveals methods and compositions derived from fully human antibodies that bind to CXCR3. These innovations hold promise for addressing a range of inflammatory disorders and cancers, showcasing Huang's dual focus on therapeutic and diagnostic applications.
Career Highlights
Dingqiu Huang is currently affiliated with Sorrento Therapeutics, Inc., where he continues to advance his research in antibody development. His work contributes to the company’s mission of innovating in the biotechnology space and improving treatment options for serious health conditions.
Collaborations
Throughout his career, Huang has collaborated with esteemed colleagues, including Barbara Anne Swanson and Heyue Zhou. These partnerships enhance the collective expertise within Sorrento Therapeutics, Inc., fostering a collaborative environment aimed at breakthrough innovations.
Conclusion
Dingqiu Huang exemplifies the spirit of innovation within the biotechnology field, with a strong emphasis on developing targeted antibody therapies. His patents not only highlight his technical knowledge but also underline the potential impact of his work on future medical treatments and diagnostics. With ongoing collaborations and a firm commitment to research, Huang continues to be a pivotal figure in the advancement of medical science.